Tanvex BioPharma Market Cap

Tanvex BioPharma has a market cap or net worth of 15.08 billion as of April 2, 2025. Its market cap has increased by 86.14% in one year.

Market Cap

15.08B

Enterprise Value

16.35B

Revenue

34.68M

Ranking

n/a

PE Ratio

n/a

Stock Price

63.30

Market Cap Chart

Since August 13, 2015, Tanvex BioPharma's market cap has decreased from 16.77B to 15.08B, a decrease of -10.11%. That is a compound annual growth rate of -1.10%.

Market Cap History

Date	Market Cap	% Change
Apr 2, 2025	15.08B	40.92%
Dec 31, 2024	10.70B	22.75%
Dec 29, 2023	8.71B	-29.59%
Dec 30, 2022	12.38B	-39.56%
Dec 30, 2021	20.48B	106.96%
Dec 31, 2020	9.89B	-9.41%
Dec 31, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
PharmaEssentia	176.51B
Caliway Biopharmaceuticals	121.22B
Bora Pharmaceuticals Co., LTD.	71.68B
Lotus Pharmaceutical	58.91B
Oneness Biotech	30.93B
Lumosa Therapeutics	29.22B
Pegavision	28.08B
Polaris Group	27.65B

Market Cap Rankings